Airway mucosal thickening and bronchial hyperresponsiveness induced by inhaled beta 2-agonist in mice

Chest
Jun TamaokiAtsushi Nagai

Abstract

Patients with chronic persistent asthma require frequent use of inhaled beta(2)-agonist, which may result in aggravation of asthma symptoms. Our recent in vitro study has shown that beta(2)-agonist stimulates the growth of human airway epithelial cell lines. To determine whether beta(2)-agonist likewise affects airway epithelial cell proliferation in vivo and, if so, what the mechanism of action is, we examined the effect of salbutamol on the morphology of murine airways. Seventy-two BALB/c mice were administered aerosolized salbutamol using "flow-through" nose-only inhalation chambers at daily doses of 0.2 to 20 microg for up to 6 weeks. Morphology of tracheal mucosa, labeling of epithelial cells with 5-bromo-2'-deoxyuridine (BrdU), and bronchial responsiveness were assessed. Exposure to salbutamol increased the thickness of tracheal epithelial layer and the number of BrdU-positive epithelial cells in a dose- and time-dependent manner: the values in mice receiving 20 microg salbutamol for 6 weeks were 247% and 642%, respectively, of those in control animals receiving saline solution alone. These effects were inhibited by the mitogen-activated protein (MAP) kinase kinase inhibitors PD98059 and U0126. Salbutamol also caused a de...Continue Reading

References

Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·C J TriggS A Hamilton
Oct 6, 1997·American Journal of Respiratory and Critical Care Medicine·E HamelmannE W Gelfand
Sep 14, 1999·The Journal of Allergy and Clinical Immunology·J E Fish, S P Peters
Dec 6, 2001·American Journal of Respiratory and Critical Care Medicine·P K Jeffery
Feb 14, 2002·Journal of Applied Physiology·S A ShoreG G Krishna Murthy
Sep 3, 2002·American Journal of Respiratory Cell and Molecular Biology·Alissa K GreenbergTheodore C Lee
Sep 3, 2002·Pediatric Pulmonology·John R CochranGiuseppe N Colasurdo
Nov 5, 2002·Lancet·Alan J Knox, Linhua Pang

❮ Previous
Next ❯

Citations

Apr 17, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Kosaku IwatsuboYoshihiro Ishikawa
Oct 25, 2006·American Journal of Respiratory and Critical Care Medicine·Bill T Ameredes, William J Calhoun
Dec 1, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Becky A Mercer, Jeanine M D'Armiento
May 3, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Maria GaluppoSalvatore Cuzzocrea
Mar 17, 2010·Molecular and Cellular Endocrinology·Yajun ZhouXiaoliang Sun
Dec 24, 2010·British Journal of Pharmacology·J K L WalkerR A Bond
Feb 24, 2010·Journal of Clinical Pharmacy and Therapeutics·N Hizawa
Jul 24, 2008·Dose-response : a Publication of International Hormesis Society·Noor DudekulaRichard A Bond
Jun 18, 2011·Allergology International : Official Journal of the Japanese Society of Allergology·Nobuyuki Hizawa
Oct 30, 2007·Allergology International : Official Journal of the Japanese Society of Allergology·Etsuko Tagaya, Jun Tamaoki
May 18, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·Xiao-Yang WangR Ilona Linnoila
Oct 12, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Selena W S SioMadhav Bhatia
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Huili ZhangMadhav Bhatia
Feb 9, 2021·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Sabry M AttiaSaleh A Bakheet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.